Skip to main content
Top

Advances in Therapy

Issue 3/2025

Content (19 Articles)

Considerations for Anthropometry Specific to People with Disproportionate Short Stature

Julie Hoover-Fong, Oliver Semler, Bobbie Barron, Paulo Ferrez Collett‑Solberg, Ellen Fung, Melita Irving, Taichi Kitaoka, Celide Koerner, Keita Okada, Katja Palm, Sérgio B. Sousa, Klaus Mohnike

Evidence Based Recommendations in Sinonasal Tumors Involving Orbit: Preservation or Exenteration? An IHNSG Guidelines

  • Guidelines

Karthik N. Rao, Cesare Piazza, Carl Snyderman, Vincent Vander Poorten, M. P. Sreeram, Primož Strojan, Ehab Hanna, Orlando Guntinas-Lichius, Fernando Lopez, Lauge Hjorth Mikkelsen, Carlos Suárez, Akihiro Homma, Silvia Babighian, Luiz P. Kowalski, Alfio Ferlito

Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East

Wael Almahmeed, Zainab Alabadla, Fatheya Al Awadi, Dalal Alrohmaihi, Mostafa AlShamiri, Hussein Elbadawi, Hassan El-Tamimi, Abdel-Nasser Elzouki, Mohamed Farghaly, Khadija Hafidh, Mohamed Hassanein, Adel Khalifa Hamad, Kamlesh Khunti, Hani Sabbour, Aletta E. Schutte

Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review

Piotr Wiland, Charlotte Both, Norman B. Gaylis, Russell D. Cohen, Jonas Halfvarson, Lena Lemke, Oliver von Richter, Andrew Blauvelt

Baseline Characteristics of the DISCOVER CKD Prospective Cohort

Carol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, Richard Ofori-Asenso, Hungta Chen, Juan Jose Garcia Sanchez, Surendra Pentakota, Roberto Pecoits-Filho, Steven Fishbane, Carolyn S. P. Lam, Naoki Kashihara, David C. Wheeler

Correction: Baseline Characteristics of the DISCOVER CKD Prospective Cohort

  • Open Access
  • Correction

Carol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, Richard Ofori-Asenso, Hungta Chen, Juan Jose Garcia Sanchez, Surendra Pentakota, Roberto Pecoits-Filho, Steven Fishbane, Carolyn S. P. Lam, Naoki Kashihara, David C. Wheeler

Health State Utility Values in Fabry Disease: Insights from the Pegunigalsidase Alfa Clinical Trials

Khashayar Azimpour, Patricia Dorling, Irene Koulinska, Swati Kunduri, Zhiyi Lan, Julia Poritz, Gabriel Tremblay, Angie Raad-Faherty

Treatment Patterns and Economic Burden of Ulcerative Colitis in Japan: A Retrospective Claims Analysis

Shingo Kato, Bruno Casaes Teixeira, Thomas Laurent, Yoshiyuki Yamada, Kiran Dave, Shweta Shah, Hyunchung Kim

Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation Who Switched from Warfarin to Direct Oral Anticoagulants in Medicare Population

Nipun Atreja, Anandkumar Dubey, Amiee Kang, Jenny Jiang, Melissa Hagan, Abimbola Michael-Asalu, Dong Cheng, Steven Deitelzweig

The Pharmacokinetics of Topical Finasteride 0.25% Spray in Chinese Adult Male Volunteers with Androgenic Alopecia: A Phase I Study

Zongguang Tai, Zhen Cui, Xinwei Shi, Haiyan Li, Rongrong Chai, Yanping Huang, Yuanyuan Fang, Danyang Jia, Quangang Zhu, Zhongjian Chen

Are Treatment Adherence Factors Apparent in Patients with Asthma and to Physicians? Results from the APPaRENT 3 Survey

Mohamed Al-Moamary, Bhumika Aggarwal, Mona Al-Ahmad, Thitiwat Sriprasart, Steven Koenig, Gur Levy, Abhay Phansalkar, Mark Silvey, Gary Milligan

Road to Hepatitis C Elimination in Israel: Improvements in Linkage to Care (2009–2020)

Ayelet A. Basson, Clara Weil, Steven E. Marx, Douglas E. Dylla, Michelle Collins, Sapir Hadadi, Gabriel Chodick, Daniella Rahamim-Cohen, Izana Kaplan Lavi, Oren Shibolet

Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands

Florian Zeevat, Simon van der Pol, Tjalke Westra, Ekkehard Beck, Maarten J. Postma, Cornelis Boersma

Phase I Study to Evaluate the Effect of Hepatic Impairment on Pharmacokinetics and Safety of Tegoprazan, a Potassium Competitive Acid Blocker

Anhye Kim, Dongseong Shin, Youlim Seo, Deborah Kang, Yang Won Min, In Hee Kim, Jungryul Kim

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study

Mark G. Lebwohl, John Y. Koo, Janusz Jaworski, Jakub Trefler, Stefan Daniluk, Anna Dudek, Wojciech Baran, Witold Owczarek, Joanna Kolinek, Paweł Brzewski, Mariusz Sikora, Marek Krogulec, SungHyun Kim, YunJu Bae, DaBee Jeon, EunJin Choi, JungBin Cha, HyunJin Lee, SuJin Choi, David M. Pariser

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar